Skip to main content
PMC home page
Scientific Reports logoLink to Scientific Reports
. 2018 Nov 9;8:16618. doi: 10.1038/s41598-018-34995-3

Embryonic Stem Cells Derived Kidney Organoids as Faithful Models to Target Programmed Nephrogenesis

Zenglai Tan 1,✉, Jingdong Shan 1, Aleksandra Rak-Raszewska 1, Seppo J Vainio 1,✉
PMCID: PMC6226521  PMID: 30413738

Abstract

The kidney is a complex organ that is comprised of thousands of nephrons developing through reciprocal inductive interactions between metanephric mesenchyme (MM) and ureteric bud (UB). The MM undergoes mesenchymal to epithelial transition (MET) in response to the signaling from the UB. The secreted protein Wnt4, one of the Wnt family members, is critical for nephrogenesis as mouse Wnt4−/− mutants fail to form pretubular aggregates (PTA) and therefore lack functional nephrons. Here, we generated mouse embryonic stem cell (mESC) line lacking Wnt4 by applying the clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated systems 9 (Cas9). We describe here, differentiation of the wild type and Wnt4 knockout mESCs into kidney progenitors, and such cells induced to undergo nephrogenesis by the mouse E11.5 UB mediated induction. The wild type three-dimensional (3D) self-organized organoids depict appropriately segmented nephron structures, while the Wnt4-deficient organoids fail to undergo the MET, as is the case in the phenotype of the Wnt4 knockout mouse model in vivo. In summary, we have established a platform that combine CRISPR/Cas9 and kidney organoid technologies to model kidney development in vitro and confirmed that mutant organoids are able to present similar actions as in the in vivo studies.

Introduction

The mammalian metanephric kidney develop from the interaction between the UB and MM cell populations, including the Six2+ Cited1+ nephron progenitor cells (NPCs) and Foxd1+stromal precursor cells1–5. The UB undergoes branching morphogenesis to form the tree-like collecting system4. The tips of the UB signal to the MM to maintain undifferentiated NPCs (Six2+Cited1+) and induce the differentiation in a subset of NPCs (Six2+Cited1−)5. The latter NPCs begin to aggregate to form the PTAs and undergo MET and become polarized, and form renal vesicles (RVs) with a lumen. RVs will sequentially transition to Comma-shaped bodies, and S-shaped bodies, eventually forming segmented nephrons, including glomeruli and adjacent proximal tubules and distal tubules6.

The Wnt4 gene encodes a signaling glycoprotein and it is expressed in multiple organs such as the embryonic metanephric kidney, the adrenal gland, the bipotential gonad, and the mammary and pituitary glands, and it plays an important role in organogenesis7–10. A homozygous missense mutation in the human WNT4 gene causes SERKAL (SEx Reversion, Kidneys, Adrenal and Lung dysgenesis) syndrome, which leads to fetal lethality11. Conventional Wnt4 knockout mouse embryos manifest several deficiencies; the kidney development is impaired at an early stage and the MET fails10. Wnt4 is expressed at the comma and S-shape stages of nephrogenesis; complete inactivation of Wnt4 in mice leads to early postnatal death, almost certainly due to the lack of kidney function10. Wnt4 signaling also controls the differentiation of the stromal cells in the embryonic kidney12. All these data shows that Wnt4 plays an important role during kidney development in vivo. However, we fail to know if Wnt4 provides such functions in developing kidney organoids in vitro.

Protocols to generate human pluripotent stem cells (hPSCs)-derived renal organoids to model human kidney development and diseases have been recently published13–17. Using appropriate chemical compounds or growth factors, developmental signaling pathways can be triggered to promote PSCs differentiation into nephron progenitors. The hPSCs-derived nephron progenitors can also undergo MET and generate mature nephrons and collecting duct structures13–17. The 3D kidney culture technology, allow human and mouse PSCs to exhibit their remarkable self-organizing properties depicted by appropriately segmented structures of nephrons14,16.

The genome engineering technique, the CRISPR/Cas9 gene editing, provides an unprecedented opportunity for studying kidney disease and development with hPSCs ex vivo. These techniques provide new resources for modelling and studying human kidney development and disease. The induction of renal lineage has been conducted using mESCs18–24 and these mESCs-derived nephron progenitor cells can be induced to nephron structures by spinal cord17. These findings show that mESCs have important potential for modelling the development as well as regeneration.

Here, we report a novel setting to be able to combine CRISPR/Cas9 with kidney organoid technologies to model kidney development. By using the CRISPR/Cas9 technique, we generated the Wnt4 deficient mESCs. We programmed differentiation of wild type and mutant mESCs into kidney progenitors and through the interaction with UB were able to induce nephrogenesis and generate kidney organoids ex vivo. We demonstrate that the Wnt4 CRISPR-knock out cells, generate kidney organoids which fail to advance the MET and lead to failure in nephrogenesis. Taken together, these results depict an innovative platform for mouse kidney development modelling and regenerative medicine application for detailed molecular genetic studies.

Results

Generation of Wnt4 deficient mESCs with double nicking by RNA-guided CRIPSR/Cas9

The mouse Wnt4 gene consists of five exons; previously reported conventional Wnt4 knockout mouse model, generated a probable null allele by replacing the whole exon 3 with a neo selection cassette10. To analyze the role of Wnt4 during kidney organoid development in vitro, we generated a Wnt4 deficient mESC line using the CRISPR/Cas9 genome editing technology. We used a pair of small guided RNAs (sgRNAs) guiding paired Cas9 nickases to knockout genes in mESCs, which have been shown to reduce the off-target activity and facilitate gene knockout efficiency in cell lines25. We designed the sgRNAs to target Wnt4 exon 2 (Fig. 1A), and constructs encoding GFP or mCherry-tagged Cas9 and sgRNAs were electroporated into the wild type mESCs. GFP and mCherry co-expressing cells were FACS sorted and positive clones were picked and expanded (Fig. 1B). Sanger-sequencing results revealed the knockout mESC line with one allele 10 bp and another allele 17 bp deletion in the Wnt4 exon 2 (Fig. 1C).

Figure 1.

Figure 1

Open in a new tab

Generation and characterization of Wnt4 knockout mESCs. (A) Schematic diagram of the location and sequences of the two sgRNAs designed to target the exon 2 of the Wnt4 gene. (B) Schematic of the double nicking by RNA-Guided CRISPR/Cas9 knockout of Wnt4 in mESCs. MEF: mouse embryonic fibroblast. (C) Chromatogram of the representative wild type and CRIPSR/Cas9 Wnt4 mutant clone. Interpretation shows separated alleles (A1 and A2) aligned against the wild type sequence. The red line represent the PAM sequence while the dotted lines indicate deletions. (D) Representative bright field images of undifferentiated wild type mESCs, and Wnt4 knockout mESCs colonies. The colonies look alike and cells do not present any differences in formation of the colonies. Scale bars: 200μm. (E) qRT–PCR results show the expression level of the stem cell markers (Sox2, Oct4, Nanog) – no significant differences between wild type mESCs and Wnt4 knockout mESCs can be observed.

We observed that the Wnt4−/− mESCs colonies were indistinguishable in size and shape from unmodified mESCs (Fig. 1D), and presented similar expression level of mESC markers such as Sox2, Oct4 and Nanog (Fig. 1E and Supplementary S1A), indicating that the Wnt4−/− cells maintained pluripotency and self-renewal properties.

Induction of intermediate mesoderm differentiation in the mouse ES cells

In order to use the CRISPR Wnt4 knockout mESCs to model kidney development in vitro we have optimized protocol to generate kidney organoids from wild type mESCs. mESCs were isolated from mouse blastocysts at E3.526,27. Activation of LIF-Stat3 or Wnt/β-catenin signaling promotes mESCs self-renewal28–30 and CHIR99021, an inhibitor of the GSK-3, induces non-neural differentiation28. We have therefore treated the mESCs with the 5 h pulse of CHIR99021 in monolayer cultures. Cells presented expression of the epiblast markers such as Fgf5 and T (Brachyury) but not the extraembryonic endoderm marker Afp (Fig. 2A, step A1 and Fig. 3A,C), suggesting direct epiblast differentiation. At 24 hours, Fgf5 was downregulated while the T marker was upregulated depicting early primitive streak differentiation (Fig. 2A, step A1 and Fig. 3A,C).

Figure 2.

Figure 2

Open in a new tab

Schematic representation of Wnt4 role during kidney development in vivo and in vitro. (A) In vitro model of Wnt4 role during kidney organoids development. (Step A1) Direct differentiation of mESCs into intermediate mesoderm (IM) cells in monolayer cultures. (Step A2) IM cells differentiation into nephron progenitors (“priming” of the pellet). (Step B1) Dissection of the UB from CD-1 mouse embryos at E11.5. (Step B2) Incubation of the UB with hGDNF for 30 min at 37 °C. (Step AB3) Aggregation of the mESC derived-nephron progenitors and hGDNF treated UB as a 3D pellet and incubation in 1.5 ml Eppendorf LoBind tube overnight. (Step AB4) Transfer of the 3D pellet to Trowel culture in DMEM basic medium supplemented with 10% FBS. (Step AB5) Maturation of the kidney organoids - giving rise to nephron structures. (Step C0) CRISPR/Cas9 knockout of Wnt4 in the mESCs. (Step CB5) Failure of kidney development in Wnt4 knockout organoids. (B) In vivo model of Wnt4 function during kidney development.

Figure 3.

Figure 3

Open in a new tab

Direct differentiation of mESCs to IM. (A) Schematic protocol of induction of IM from mESCs. (B) Phase contrast images of mESCs in monolayer (2D) cultures during differentiation into IM. Consecutive days are shown, with day 0 indicating the time point immediately before CHIR99021 treatment. Scale bars, 200 µm. (C) RT-PCR of mESCs differentiation presenting gene expression changes during CHIR treatment, after 5 hours and 1 day; cells expressed epiblast markers Fgf5 and T but no extraembryonic endoderm marker Afp. (D) RT–PCR presenting gene expression changes during further CHIR differentiation of mESCs; day 1 and 2 showing the expression of primitive streak markers (Mixl1, T, Tbx6) but no ectodermal markers (Pax6 and Sox1). (E) RT–PCR at day 8 of differentiation showing the expression of markers of IM (Osr1, Pax2, Lhx1, Gata3, Wt1, Eya1, Cited2, Hoxd11) while ectodermal marker Pax6 was not detected. E16.5 Kidney cDNA was used as a positive control. NC, negative control with no DNA template. (C–E) Full-length gels are presented in Supplementary Information.

The canonical Wnt signaling pathway induces primitive streak development in mESCs and hESCs31,32. The intermediate mesoderm (IM) arises from the primitive streak. Fibroblast growth factor 9 (Fgf9) is expressed in IM33 and FGF9 signaling supports MM differentiation in vitro34. Previous studies demonstrated that differentiation of IM from hPSCs requires CHIR99021-to-FGF913,14, we therefore analyzed whether mESCs-derived epiblast cells reacted similarly to the Wnt and FGF signaling. We treated these cells with CHIR99021 for 48 h and found expression of primitive streak markers such as Mixl1, T and Tbx6 (Fig. 2, step A1 and Fig. 3A,D), implicating early mesendoderm differentiation. Indeed, FGF signaling was required for generation of the IM cells. In the presence of FGF9 and heparin, these cells advanced their differentiation and their growth dynamics changed from a monolayer-type towards cellular clusters (Fig. 3B). The cells isolated at day 8 of differentiation expressed Osr1, Pax2, Lhx1, Wt1, Ctied2, Eya1, Hoxd11 and Gata3 genes (Fig. 3E). These genes are typically expressed in the cells of IM associated with kidney lineages19. In summary, we have established a novel protocol to induce the mESCs towards the IM stage in a monolayer culture setting with CHIR99021-FGF9/heparin supplementation (Fig. 3A).

Generation of kidney organoids from mESCs-derived nephron progenitors with embryonic UB

Nephron Progenitor Cells (NPCs, Six2+ cells) purified from mouse embryonic kidney present long-term self-renewal properties when cultured in the medium enabling NPC self-renewal (NPSR)35. The NPSR medium mimics the in vivo nephron progenitor niche by delivering important small molecules and necessary growth factors to maintain undifferentiated progenitor cell proliferation and self-renewal35. To test, whether NPSR can indeed induce the NPCs from the mESCs-derived IM cells, we harvested these cells at day 8 of differentiation and cultured them as 3D pellets in the NPSR medium overnight (Fig. 2, step A2 and Supplementary Fig. S2A). This process enhanced expression of the NPC markers, such as Cited2, Wt1, Hoxd11, and Six2 (Fig. 4A,B). Incubation of the mESCs-derived IM cells in the NPSR medium overnight was a necessary step in priming these IM cells for renal differentiation. If this step was omitted, the nephrogenesis in the IM cells failed to be induced by the UB (Supplementary Fig. S2C).

Figure 4.

Figure 4

Open in a new tab

Generation of kidney organoids through aggregation of mESC-derived nephron progenitor cells and embryonic UB. (A) Schematic of the differentiation protocol of mESCs into kidney organoids. (B) Electrophoresis gel of RT-PCR products presenting kidney lineage cells expressing nephron progenitor markers Cited2, Wt1, Hoxd11, and Six2 after incubation in NPSR medium overnight. (C) Global bright field images of kidney organoids in Trowel culture. Scale bars: 500 μm. (D–F) Whole-mount immunofluorescence analyses of the organoids showing nephron progenitor markers: (D) glomeruli marker - Wt1, (E) proximal tubule marker - LTL, (F) nephron marker - Pax2. Scale bars: 20μm. (G) Confocal image showing three compartments of segmented nephron, including the distal tubule (DT, Pax2 + LTL−), proximal tubule (PT, LTL+) and the glomerulus (G, Wt1+). Dotted box shows single nephron that was used to generate a schematic diagram in (G’). Scale bars: 20 μm.

We reported recently that the UB separated from mouse embryos (E11.5) induces MET and nephrogenesis in an intact and dissociated to single cells and re-aggregated E11.5 MM36. Hence, we have used the mouse E11.5 UB tissue as a potent nephrogenesis inducer. We aggregated “primed” 3D pellets with the UB and cultured in 3D Trowell culture system. This led to successful nephrogenesis induction (Fig. 2, steps B1-AB5 and Fig. 4C) depicted by positive staining for glomerulus marker: Wilms tumor 1 (Wt1+, yellow; Fig. 4D); proximal tubule marker: Lotus tetragonolobus lectin (LTL+, green; Fig. 4E); and distal tubule marker: (Pax2+ LTL−, red; Fig. 4F), suggesting proper differentiation of cultured organoids to major segments of the nephrons. We also found numerous Wt1+ glomeruli adjacent to the LTL+ proximal tubules, and LTL+ proximal tubules connected with Pax2+ LTL− distal tubules (Fig. 4G, G’).

To verify, that the kidney organoid structures were generated via the interaction between the UB and the mESCs-derived kidney cells, but not by contaminated UB tip cells with the primary MM cells, we cultured the E11.5 UB tissue in isolation in the 3D culture. The UB cells underwent apoptosis already at the second day of culture and died at day 3 (Supplementary Fig. S2B). In addition, there is lack of nephron structures formation when “un-primed” IM cells were aggregated with UB or the IM cells “primed” in NPSR medium were transferred to 3D culture without integration with the UB (Supplementary Fig. S2C,D). These data suggest that the mESCs-derived IM cells can differentiate into nephron progenitors via a “priming step”. Such cells are also competent to undergo the MET and generate 3D kidney organoid when induced with the embryonic UB.

Wnt4 regulates nephrogenesis in kidney organoids

Wnt-signaling play multiple roles in different tissues during development. It regulates the pattern formation, cell fate choices, cell renewal, proliferation and migration28,37–40. Wnt4 is important for kidney development; it is the mesenchymal signal for epithelial transformation of MM in the developing kidney10 and is expressed in the kidney mesenchyme and its derivatives, namely the nephrons41–44. Mouse mutants with loss of Wnt4 fail to form PTAs and therefore lack functional nephrons10.

To investigate whether Wnt4 would play the same role during kidney organoid development, we generated the Wnt4−/− organoids with the CRISPR/Cas9 knockout Wnt4 mESC line. The differentiation conditions of Wnt4−/− organoids were the same as the wild type mESCs organoids (Fig. 2A). There is no visible morphology difference between wild type and Wnt4−/− mESCs when differentiated to IM population (Fig. 5A and Supplementary S2B); 3D pellets show no distinction before and after priming step (Supplementary S2A and S3D). In addition, Wnt4−/− mESCs differentiated to kidney lineage present expression of the same markers as the wild type cells during all differentiation stages (Supplementary S3A–C, E,F). These data show that Wnt4−/− mESCs were able to differentiate into kidney lineage.

Figure 5.

Figure 5

Open in a new tab

Lack of mesenchyme to epithelial transition (MET) in Wnt4 CRISPR-mutant kidney organoids. (A) Phase contrast images of Wnt4 knockout mESCs in monolayer (2D) cultures during differentiation into IM. Consecutive days are shown. Scale bars: 200 µm. (B) Global bright field images of the Wnt4 knockout kidney organoids in Trowel culture. Scale bars: 500μm. (C) Immunological characterization of structures within wild type and Wnt4 knockout kidney organoids. Scale bars: 20 μm.

We used these Wnt4−/− kidney lineage cells to aggregate with the wild type UB to make the organoids (Fig. 2A, step CB5). In contrast to the wild type organoids (Fig. 4C), the 3D morphology of the Wnt4−/− organoids appeared to be flatter (Fig. 5B). These organoids failed to undergo nephrogenesis and did not generated any kidney structures, as depicted on Fig. 5C with immunostaining for nephron specific markers (Fig. 5C and Supplementary Fig. S4A). The, Wnt4−/− organoid failed to undergo the MET and subsequently kidney development failed, as is the case in the in vivo model (Fig. 2A,B and Supplementary Fig. S4B). In conclusion, Wnt4 signal is crucial to regulate epithelial transformation of nephron progenitors in the developing kidney organoids. Moreover, organoids are a good tool to study and model development.

Discussion

Recent advances in genome editing and stem cell-derived kidney organoid technologies provide the possibility to perform sophisticated genetic studies in PSC-derived kidney lineage. Several groups reported using gene-editing settings to study kidney development and disease in the organoids. Recapitulated features of glomerular and tubular diseases by transiently transfecting undifferentiated hPSCs with plasmids expressing wild type Cas9 and sgRNAs targeting disease-relevant genes PODXL (podocalyxin like), polycystic kidney disease (PKD) genes PKD1 and PKD245,46 and TALEN knockout PAX2 to study UB development in vitro16,47. Here, we report for the first time using the double nicking by RNA-guided CRISPR/Cas9 technique to knockout of Wnt4 in the mESCs and study kidney development in vitro.

Mouse ESC lines possess the ability to differentiate into a variety of cell types, and therefore are a source of cells for functional studies48,49. Usually, mESCs differentiation starts with embryoid body (EB) formation as a way of following normal developmental events that take place in the embryo50. However, here we have developed a 2D monolayer culture method to successfully differentiate mESCs into epiblast. We further differentiated the epiblast stage cells into IM cell population using CHIR99021-FGF9/heparin treatment. Our studies revealed that using Wnt and Fgf signaling we could efficiently differentiate mESCs into kidney precursor cells in 2D cultures. With previously reported high efficiency of maintaining nephron progenitor’s stemness in NPSR medium35, we managed to direct the differentiation of IM into nephron progenitors in a 3D pellet in this medium. This incubation - “priming” step, appeared to be crucial in derivation of NPC from IM that would be competent to undergo nephrogenesis. Our method illustrates that the nephron progenitors derived from mESCs gain the potential to interact with the functional UB and are competent to advance the nephrogenesis.

Human WNT4 mutation causes kidneys dysgenesis syndrome and mouse knockout of Wnt4 leads to a failure in kidney development (kidney agenesis). Our studies of Wnt4 knockout in mESCs illustrate that combining of CRISPR/Cas9 genome editing technology to determine the function of specific genes in different mouse cell types, with 3D generation of organoids leads to similar effects as an in vivo study. Moreover, we believe that the mESC Wnt4−/−-derived NPCs behave similarly to MM. These cells express many markers of competent MM before combining them with freshly isolated UB (Supplementary Fig. S3E), however, after 8 days of culture as an organoid, the Wt1 and Pax2 are lost (Fig. 5) and there are no nephrons present. Normally, MM stays competent for induction signal from the UB for 24–36 h51, and lack of it leads to apoptosis of these cells. Also UB undergoes apoptosis if no signals reach it from the MM52 (Supplementary Fig. S2B). Given that, in these mutant organoids the Wnt9b from the UB has no cells to act upon (all being Wnt4−/−)10, it is no surprising that the nephrogenesis fails and all MM markers are lost.

The CRISPR/Cas9 technology has enabled efficient creation of various disease models, in our work and of others45,53 proving that generation of renal organoids from gene-modified PSCs provide an excellent tool and endless possibilities to model kidney development and disease. These are important breakthroughs, which will promote the development of regenerative medicine.

In summary, we showed here wild type mESCs-derived nephron progenitors aggregated with primary UB formed kidney organoids with full nephron structures. While genome-modified nephron progenitors (Wnt4−/−) aggregated with UB formed mutant organoids with failed kidney development, which functionally recapitulate kidney development phenotypes in vivo. The described methodologies (Fig. 2A) are broadly relevant for functional studies of factors involved in development and their potential in regenerative medicine. In the long term, this system may provide a useful setting that will benefit personalized medicine and gene therapy.

Materials and Methods

The animal care and experimental procedures in this study were in accordance with Finnish national legislation on the use of laboratory animals, the European Convention for the protection of vertebrate animal used for experimental and other scientific purposes (ETS 123), and the EU Directive 86/609/EEC. The animal experimentation was also authorized by the Finnish National Animal Experiment Board (ELLA) as being compliant with the EU guidelines for animal research and welfare.

Mouse ESCs culture

All experiments used the wild type mouse embryonic stem cells derived from Taconic’s W4/129S6 inbred mouse strain. Undifferentiated wild type and the CRISPR/Cas9 knockout mESCs were maintained on the mouse embryonic fibroblasts (MEFs) as a feeder layer with mESCs medium as previously reported54.

CRISPR/Cas9 genome editing

Cas9 nickase was used for editing the second exon of the Wnt4 gene following the protocol of the Zhang Feng’s lab, MIT (https://www.addgene.org/crispr/zhang/). pSpCas9n (BB)-2A-GFP (AddGene: PX461) was modified by replacing 2A-GFP with 2A-mCherry. Paired oligoes corresponding to Wnt4 gRNA1 (5′-TCGAGGAGTGCCAATACCAG-3′) were cloned into pSpCas9n (BB)-2A-GFP vector. Paired oligoes corresponding to Wnt4 gRNA2 (5′-GCGCTGGAACTGTTCCACAC-3′) were cloned into pSpCas9n (BB)-2A-mCherry vector. Paired GFP and mCherry constructs were co-electroporated into mESCs. GFP and mCherry double positive cells were isolated by flow cytometry sorting (FACS) two days after electroporation, and immediately plated onto the 10 cm MEF coated plate. One to two weeks later, there were colonies growing in the culture plate. Using 100 μl pipette tips we picked up the colonies and placed them individually in the 96 well culture plate filled with trypsin. After dissociation into single cells, the colonies were transferred onto MEF-coated 24-well plates and then expanded in 10 cm plates separately. Further, the genotyping by PCR/TA-cloning and chromatogram sequencing were used to analyze the mutations and select the positive clones for analysis and differentiation experiments. The primers (5′–3′) used for genotyping: Wnt4 forward: GTATCACATCCAACCACTG, reverse: AGAAGCCTGATGCCAAGGGA.

Cell differentiation

Mouse ESCs were cultured in Matrigel-coated 6 cm culture dishes, in mESCs medium until reaching 70–90% confluency. mESCs were passaged on Matrigel-coated 6 cm plates at 30,000 cells/cm2. Next day, cells reached 80–90% of confluency and were treated with 8 μM CHIR99021 in APEL basal medium (STEMCELL Technologies) for 4 days, followed by FGF9 (200 ng/ml) and heparin (1 μg/ml) treatment for another 4 days; medium was changed every other day. Following the differentiation, there were some floating cells; these were apoptotic cells and were removed during changing medium.

3D kidney organoids formation

At day 8 of differentiation, cells were collected and dissociated into single cell suspension using TrypLE select (Life Technologies). Cells (3 × 105) were centrifuged at 1000 rpm for 4 min to form a pellet and were incubated overnight (ON) with NPSR medium in U-bottom low-attachment 96-well plates (Thermo, Cat. No. 174929) at 37 °C and 5% CO2. After ON incubation, the cellular pellet was aggregated with freshly dissected and 30 mins hrGDNF (PeproTech) treated E11.5 UBs as described previously36. The aggregated pellets were centrifuged at 1000 rpm 4 min and kept in the 1.5 ml Eppendorf LoBind tubes with DMEM and 10% fetal bovine serum (FBS) medium ON. Next day, the pellets formed 3D aggregates at the bottom of the tubes and were transferred into a Trowell-type culture onto 0.1 μm or 1 μm pore polyester membrane and cultured for around 8 days in DMEM supplemented with 10% FBS medium at 37 °C and 5% CO2; medium was changed every other day.

RT-PCR

An RNeasy kit (Qiagen) was used according to the manufacturer’s recommendations to extract the total RNA. cDNA synthesis (First Strand cDNA Synthesis Kit, ThermoFisher) was performed using standard protocols. qRT-PCR analyses were displayed with SYBR Green (Agilent) by an CFX96 Real-Time PCR machine. The Brilliant III SYBR® Green QPCR Master Mix (Agilent Technologies) was used according to the manufacturer’s instructions. The GAPDH probe served as a control to normalize the data. The gene expression experiments were performed in triplicates on three independent experiments. All the Primers sequences are given in Table S1.

Whole mount immunostaining

For the immunostaining, the wild type and Wnt4−/− kidney organoids were used at the same time, and treated as a control to each other. The kidney organoids were washed two times with 1x PBS and fixed with 100% cold Methanol (−20 °C pre-chilled) for 30 min, washed at least 3 times in 1x PBS before immunostaining. For immunostaining, the organoids were blocked in 0.1% Triton-X100, 1% BSA and 10% goat serum/0.02 M glycine-PBS for 1–3 hours at room temperature. Following blocking, the organoids were incubated ON in primary antibodies against Wt1 (1:100, #05–753, Millipore), Pax2 (1:200, #PRB-276P, Covance), in blocking buffer overnight at 4 °C. Next day, the organoids were washed with 1x PBS six times and incubated ON in 1x PBS with goat anti-rabbit IgG Alexa Fluor 546 (1:1000; #A11010, Life technologies), goat anti-mouse IgG Alexa Fluor 647 (1:1000; #A21235, Life technologies) and fluorescein anti-LTL (1:350, #FL-1321, Vector Laboratories) at 4 °C. A Zeiss LSM780 microscope and Zeiss Axiolab were used for image capture and analysis. Wild type and Wnt4−/− kidney organoids were imaged using the same settings of the microscope.

Electronic supplementary material

Supplementary Information (1.3MB, pdf)

Acknowledgements

We thank Paula Haipus, Hannele Härkman, Johanna Kekolahti-Liias, Sanna Kauppinen and Denis Zosen for technical assistance, Dr. Florence Naillat, Dr. Ilya Skovorodkin and Abhishek Sharma for the discussion, Biocenter Oulu Transgenic core facility for the mouse ESCs. We also thank Dr. Fariba Jian Motamedi and Prof. Andreas Schedl for their technical support, discussions and critical comments to this manuscript. This work was supported by H2020 Marie Skłodowska-Curie Actions Innovative Training Network “RENALTRACT”, (Project ID 642937), Centre of Excellence grant (2012-2017 251314), the European Community’s Seventh Framework Programme (FP7/2007-2013; grant FP7-HEALTH-F5-2012-INNOVATION-1 EURenOmics 305608) and Finnish Cultural Foundation (personal grant to A.R.R).

Author Contributions

Z.T., A.R.-R. and S.J.V. designed the study; Z.T. performed most experiments; J.S. cloned the Wnt4 CRIPSR/Cas9 vectors; Z.T. made the figures and wrote the original draft, A.R.-R. and S.J.V. revised the paper; all authors approved the final version of the manuscript.

Data Availability

The datasets generated and/or analyzed during the current study are available from the corresponding author on request.

Competing Interests

The authors declare no competing interests.

Footnotes

Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Contributor Information

Zenglai Tan, Email: zenglai.tan@oulu.fi.

Seppo J. Vainio, Email: seppo.vainio@oulu.fi

Electronic supplementary material

Supplementary information accompanies this paper at 10.1038/s41598-018-34995-3.

References

  • 1.Saxén L, Sariola H. Early organogenesis of the kidney. Pediatr. Nephrol. 1987;1:385–392. doi: 10.1007/BF00849241. [DOI] [PubMed] [Google Scholar]
  • 2.Vainio S, Lin Y. Coordinating early kidney development: lessons from gene targeting. Nat. Rev. Genet. 2002;3:533–543. doi: 10.1038/nrg842. [DOI] [PubMed] [Google Scholar]
  • 3.Dressler GR. The cellular basis of kidney development. Annu. Rev. Cell Dev. Biol. 2006;22:509–529. doi: 10.1146/annurev.cellbio.22.010305.104340. [DOI] [PubMed] [Google Scholar]
  • 4.Costantini F, Kopan R. Patterning a complex organ: branching morphogenesis and nephron segmentation in kidney development. Dev. Cell. 2010;18:698–712. doi: 10.1016/j.devcel.2010.04.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Brown AC, et al. Role for compartmentalization in nephron progenitor differentiation. Proc. Natl. Acad. Sci. USA. 2013;110:4640–4645. doi: 10.1073/pnas.1213971110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Georgas K, et al. Analysis of early nephron patterning reveals a role for distal RV proliferation in fusion to the ureteric tip via a cap mesenchyme-derived connecting segment. Dev. Biol. 2009;332:273–286. doi: 10.1016/j.ydbio.2009.05.578. [DOI] [PubMed] [Google Scholar]
  • 7.Brisken C, et al. Essential function of Wnt-4 in mammary gland development downstream of progesterone signaling. Genes Dev. 2000;14:650–654. [PMC free article] [PubMed] [Google Scholar]
  • 8.Heikkilä M, et al. Wnt-4 deficiency alters mouse adrenal cortex function, reducing aldosterone production. Endocrinology. 2002;143:4358–4365. doi: 10.1210/en.2002-220275. [DOI] [PubMed] [Google Scholar]
  • 9.Potok MA, et al. WNT signaling affects gene expression in the ventral diencephalon and pituitary gland growth. Dev. Dyn. 2008;237:1006–1020. doi: 10.1002/dvdy.21511. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Stark K, Vainio S, Vassileva G, McMahon AP. Epithelial transformation of metanephric mesenchyme in the developing kidney regulated by Wnt-4. Nature. 1994;372:679–683. doi: 10.1038/372679a0. [DOI] [PubMed] [Google Scholar]
  • 11.Mandel H, et al. SERKAL syndrome: an autosomal-recessive disorder caused by a loss-of-function mutation in WNT4. Am. J. Hum. Genet. 2008;82:39–47. doi: 10.1016/j.ajhg.2007.08.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Itäranta P, et al. Wnt-4 signaling is involved in the control of smooth muscle cell fate via Bmp-4 in the medullary stroma of the developing kidney. Dev. Biol. 2006;293:473–483. doi: 10.1016/j.ydbio.2006.02.019. [DOI] [PubMed] [Google Scholar]
  • 13.Takasato M, et al. Directing human embryonic stem cell differentiation towards a renal lineage generates a self-organizing kidney. Nat. Cell Biol. 2014;16:118–126. doi: 10.1038/ncb2894. [DOI] [PubMed] [Google Scholar]
  • 14.Takasato M, et al. Kidney organoids from human iPS cells contain multiple lineages and model human nephrogenesis. Nature. 2015;526:564–568. doi: 10.1038/nature15695. [DOI] [PubMed] [Google Scholar]
  • 15.Morizane R, et al. Nephron organoids derived from human pluripotent stem cells model kidney development and injury. Nat. Biotechnol. 2015;33:1193–1200. doi: 10.1038/nbt.3392. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Taguchi, A. & Nishinakamura, R. Higher-Order Kidney Organogenesis from Pluripotent Stem Cells. Cell Stem Cell (2017). [DOI] [PubMed]
  • 17.Taguchi A, et al. Redefining the in vivo origin of metanephric nephron progenitors enables generation of complex kidney structures from pluripotent stem cells. Cell Stem Cell. 2014;14:53–67. doi: 10.1016/j.stem.2013.11.010. [DOI] [PubMed] [Google Scholar]
  • 18.Kobayashi T, et al. Wnt4-transformed mouse embryonic stem cells differentiate into renal tubular cells. Biochem. Biophys. Res. Commun. 2005;336:585–595. doi: 10.1016/j.bbrc.2005.08.136. [DOI] [PubMed] [Google Scholar]
  • 19.Kim D, Dressler GR. Nephrogenic factors promote differentiation of mouse embryonic stem cells into renal epithelia. J. Am. Soc. Nephrol. 2005;16:3527–3534. doi: 10.1681/ASN.2005050544. [DOI] [PubMed] [Google Scholar]
  • 20.Vigneau C, et al. Mouse embryonic stem cell-derived embryoid bodies generate progenitors that integrate long term into renal proximal tubules in vivo. J. Am. Soc. Nephrol. 2007;18:1709–1720. doi: 10.1681/ASN.2006101078. [DOI] [PubMed] [Google Scholar]
  • 21.Bruce SJ, et al. In vitro differentiation of murine embryonic stem cells toward a renal lineage. Differentiation. 2007;75:337–349. doi: 10.1111/j.1432-0436.2006.00149.x. [DOI] [PubMed] [Google Scholar]
  • 22.Batchelder CA, Lee CCI, Matsell DG, Yoder MC, Tarantal AF. Renal ontogeny in the rhesus monkey (Macaca mulatta) and directed differentiation of human embryonic stem cells towards kidney precursors. Differentiation. 2009;78:45–56. doi: 10.1016/j.diff.2009.05.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Morizane R, Monkawa T, Itoh H. Differentiation of murine embryonic stem and induced pluripotent stem cells to renal lineage in vitro. Biochem. Biophys. Res. Commun. 2009;390:1334–1339. doi: 10.1016/j.bbrc.2009.10.148. [DOI] [PubMed] [Google Scholar]
  • 24.Mae S, et al. Combination of small molecules enhances differentiation of mouse embryonic stem cells into intermediate mesoderm through BMP7-positive cells. Biochem. Biophys. Res. Commun. 2010;393:877–882. doi: 10.1016/j.bbrc.2010.02.111. [DOI] [PubMed] [Google Scholar]
  • 25.Ran F, et al. Double Nicking by RNA-Guided CRISPR Cas9 for Enhanced Genome Editing Specificity. Cell. 2013;155:479–480. doi: 10.1016/j.cell.2013.09.040. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Evans MJ, Kaufman MH. Establishment in culture of pluripotential cells from mouse embryos. Nature. 1981;292:154–156. doi: 10.1038/292154a0. [DOI] [PubMed] [Google Scholar]
  • 27.Martin GR. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc. Natl. Acad. Sci. USA. 1981;78:7634–7638. doi: 10.1073/pnas.78.12.7634. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Ying Q, et al. The ground state of embryonic stem cell self-renewal. Nature. 2008;453:519–523. doi: 10.1038/nature06968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Niwa H, Burdon T, Chambers I, Smith A. Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3. Genes Dev. 1998;12:2048–2060. doi: 10.1101/gad.12.13.2048. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Matsuda T, et al. STAT3 activation is sufficient to maintain an undifferentiated state of mouse embryonic stem cells. EMBO J. 1999;18:4261–4269. doi: 10.1093/emboj/18.15.4261. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Sumi T, Tsuneyoshi N, Nakatsuji N, Suemori H. Defining early lineage specification of human embryonic stem cells by the orchestrated balance of canonical Wnt/beta-catenin, Activin/Nodal and BMP signaling. Development. 2008;135:2969–2979. doi: 10.1242/dev.021121. [DOI] [PubMed] [Google Scholar]
  • 32.Gadue P, Huber TL, Paddison PJ, Keller GM. Wnt and TGF-beta signaling are required for the induction of an in vitro model of primitive streak formation using embryonic stem cells. Proc. Natl. Acad. Sci. USA. 2006;103:16806–16811. doi: 10.1073/pnas.0603916103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Colvin JS, Feldman B, Nadeau JH, Goldfarb M, Ornitz DM. Genomic organization and embryonic expression of the mouse fibroblast growth factor 9 gene. Dev. Dyn. 1999;216:72–88. doi: 10.1002/(SICI)1097-0177(199909)216:1<72::AID-DVDY9>3.0.CO;2-9. [DOI] [PubMed] [Google Scholar]
  • 34.Barak H, et al. FGF9 and FGF20 maintain the stemness of nephron progenitors in mice and man. Dev. Cell. 2012;22:1191–1207. doi: 10.1016/j.devcel.2012.04.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Li Z, et al. 3D Culture Supports Long-Term Expansion of Mouse and Human Nephrogenic Progenitors. Cell Stem Cell. 2016;19:516–529. doi: 10.1016/j.stem.2016.07.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Junttila S, et al. Functional genetic targeting of embryonic kidney progenitor cells ex vivo. J. Am. Soc. Nephrol. 2015;26:1126–1137. doi: 10.1681/ASN.2013060584. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Chien AJ, Randall T Moon. WNTS and WNT receptors as therapeutic tools and targets in human disease processes. Frontiers in bioscience: a journal and virtual library. 2007;12:448–457. doi: 10.2741/2074. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Chien AJ, Moon RT. WNTS and WNT receptors as therapeutic tools and targets in human disease processes. Front Biosci. 2007;12:448–457. doi: 10.2741/2074. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Rajaram RD, et al. Progesterone and Wnt4 control mammary stem cells via myoepithelial crosstalk. The EMBO Journal. 2015;34:641–652. doi: 10.15252/embj.201490434. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Vidal V, et al. The adrenal capsule is a signaling center controlling cell renewal and zonation through Rspo3. Genes Dev. 2016;30:1389–1394. doi: 10.1101/gad.277756.116. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Shan J, Jokela T, Peltoketo H, Vainio S. Generation of an allele to inactivate Wnt4 gene function conditionally in the mouse. Genesis. 2009;47:782–788. doi: 10.1002/dvg.20566. [DOI] [PubMed] [Google Scholar]
  • 42.Shan J, Jokela T, Skovorodkin I, Vainio S. Mapping of the fate of cell lineages generated from cells that express the Wnt4 gene by time-lapse during kidney development. Differentiation. 2010;79:57–64. doi: 10.1016/j.diff.2009.08.006. [DOI] [PubMed] [Google Scholar]
  • 43.Murugan S, et al. WT1 and Sox11 regulate synergistically the promoter of the Wnt4 gene that encodes a critical signal for nephrogenesis. Exp. Cell Res. 2012;318:1134–1145. doi: 10.1016/j.yexcr.2012.03.008. [DOI] [PubMed] [Google Scholar]
  • 44.Prunskaite-Hyyryläinen R, et al. Wnt4 coordinates directional cell migration and extension of the Müllerian duct essential for ontogenesis of the female reproductive tract. Hum. Mol. Genet. 2016;25:1059–1073. doi: 10.1093/hmg/ddv621. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Freedman BS, et al. Modelling kidney disease with CRISPR-mutant kidney organoids derived from human pluripotent epiblast spheroids. Nat Commun. 2015;6:8715. doi: 10.1038/ncomms9715. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Cruz NM, et al. Organoid cystogenesis reveals a critical role of microenvironment in human polycystic kidney disease. Nat Mater. 2017;16:1112–1119. doi: 10.1038/nmat4994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Kaku Y, et al. PAX2 is dispensable for in vitro nephron formation from human induced pluripotent stem cells. Sci Rep. 2017;7:4554. doi: 10.1038/s41598-017-04813-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Doetschman TC, Eistetter H, Katz M, Schmidt W, Kemler R. The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium. J Embryol Exp Morphol. 1985;87:27–45. [PubMed] [Google Scholar]
  • 49.Keller G. Embryonic stem cell differentiation: emergence of a new era in biology and medicine. Genes Dev. 2005;19:1129–1155. doi: 10.1101/gad.1303605. [DOI] [PubMed] [Google Scholar]
  • 50.Rak-Raszewska A, et al. Development of embryonic stem cells in recombinant kidneys. Organogenesis. 2012;8:125–136. doi: 10.4161/org.22597. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Dudley AT, Godin RE, Robertson EJ. Interaction between FGF and BMP signaling pathways regulates development of metanephric mesenchyme. Genes Dev. 1999;13:1601–1613. doi: 10.1101/gad.13.12.1601. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Donovan MJ, et al. Initial differentiation of the metanephric mesenchyme is independent of WT1 and the ureteric bud. Dev. Genet. 1999;24:252–262. doi: 10.1002/(SICI)1520-6408(1999)24:3/4<252::AID-DVG8>3.0.CO;2-K. [DOI] [PubMed] [Google Scholar]
  • 53.Cruz NM, et al. Organoid cystogenesis reveals a critical role of microenvironment in human polycystic kidney disease. Nat Mater. 2017;16:1112–1119. doi: 10.1038/nmat4994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Porret A, Mérillat A, Guichard S, Beermann F, Hummler E. Tissue-specific transgenic and knockout mice. Methods Mol. Biol. 2006;337:185–205. doi: 10.1385/1-59745-095-2:185. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary Information (1.3MB, pdf)

Data Availability Statement

The datasets generated and/or analyzed during the current study are available from the corresponding author on request.

Articles from Scientific Reports are provided here courtesy of Nature Publishing Group

RESOURCES